BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers-Reference-Cited by-同舟云学术

BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers

Published:2016-05-09 Issue:7 Volume:17 Page:851-860
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Roychoudhuri Rahul,Clever David,Li Peng,Wakabayashi Yoshiyuki,Quinn Kylie M,Klebanoff Christopher A,Ji Yun,Sukumar Madhusudhanan,Eil Robert L,Yu Zhiya,Spolski Rosanne,Palmer Douglas C,Pan Jenny H,Patel Shashank J,Macallan Derek C,Fabozzi Giulia,Shih Han-Yu,Kanno Yuka,Muto Akihiko,Zhu Jun^ORCID,Gattinoni Luca^ORCID,O'Shea John J,Okkenhaug Klaus^ORCID,Igarashi Kazuhiko,Leonard Warren J,Restifo Nicholas P

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3441.pdf

Reference57 articles.

1. Kaech, S.M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749–761 (2012).

2. Belz, G.T. & Kallies, A. Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination. Curr. Opin. Immunol. 22, 279–285 (2010).

3. D'Cruz, L.M., Rubinstein, M.P. & Goldrath, A.W. Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin. Immunol. 21, 92–98 (2009).

4. Williams, M.A. & Bevan, M.J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171–192 (2007).

5. Restifo, N.P. & Gattinoni, L. Lineage relationship of effector and memory T cells. Curr. Opin. Immunol. 25, 556–563 (2013).

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma;Nature Communications;2024-09-08

2. Distinct epigenomic landscapes underlie tissue-specific memory T cell differentiation;Immunity;2024-09

3. NaCl enhances CD8+ T cell effector functions in cancer immunotherapy;Nature Immunology;2024-08-28

4. LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling;Signal Transduction and Targeted Therapy;2024-08-09

5. BACH2 regulates diversification of regulatory and proinflammatory chromatin states in TH17 cells;Nature Immunology;2024-07-15